Articles related to BUSINESS & POLICY

The comparative modeling analysis of gene therapy for sickle cell disease underscores its potential cost-effectiveness and value in enhancing patient quality of life. With estimated ICERs significantly varying under different perspectives, the findings advocate for a nuanced approach to assessing novel therapies within the broader healthcare landscape.

In 2024, the orthopedics sector anticipates shifts in procedure backlogs, pricing strategies, and the adoption of advanced technologies, signaling a pivotal year for surgeons and patient care.

The recent suspension of the oncology program at Trios Health, due to a shortage of medical oncologists, highlights a growing national challenge in healthcare staffing, particularly in non-urban areas.

Stay informed on the CDC’s new mandate for antibiotic use and resistance reporting – a pivotal step towards enhancing antimicrobial stewardship and patient care in US hospitals.

In the latest examination of DSM-5-TR, it’s revealed that nearly 60% of its panel members received payments from the pharmaceutical industry, highlighting the pervasive nature of financial conflicts in shaping psychiatric standards.

The lawsuit against HCA Healthcare highlights the critical importance of maintaining agreed-upon services in healthcare systems. The alleged service lapses could have far-reaching implications for patient care and the broader healthcare industry.